Zydus Cadila Chief Passes On Baton To Scion
Cadila Healthcare’s scion Dr Sharvil Patel takes charge as managing director as the frontline Indian company transitions to its next phase of growth and aspires for a more innovation-driven avatar.
You may also be interested in...
Zydus Cadila is teaming up with Canada’s Medicure Inc to launch cholesterol control medication Zypitamag, its first branded drug in the key US market, as the Indian firm drives ahead with a strategy of diversifying from low-priced generics.
Shares of Cadila Healthcare were pounded on Indian bourses on New Year's Eve after the US FDA issued warning letters against two of the firm's Indian sites, though the company's top brass stressed that de-risking efforts, by way of site transfers for critical products, were already underway.
Tildrakizumab debuts in Japan, marking a key milestone for Sun Pharma, though heavyweight competitors including same class rival Skyrizi are already available on the market there.